Furthermore, the REPOSE trial, which observed adults with type 1 diabetes, discovered that the utilization of insulin pump therapy was linked to a higher occurrence of hypoglycemia episodes compared to MDI throughout a two-year follow-up period [30]. The gene discussed is INS; the disease is Hypoglycemia.